Published 22 July 2008, doi:10.1136/bmj.a478
Cite this as: BMJ 2008;337:a478

Research

Contribution of problem drug users’ deaths to excess mortality in Scotland: secondary analysis of cohort study

Michael Bloor, professorial research fellow1, Maria Gannon, research fellow1, Gordon Hay, senior research fellow1, Graham Jackson, head of branch (retired)2, Alastair H Leyland, senior research scientist3, Neil McKeganey, director1

1 Centre for Drug Misuse Research, University of Glasgow, Glasgow G11 6PW, 2 Vital Events Branch, General Register Office for Scotland, Edinburgh EH12 7TF, 3 MRC Social and Public Health Sciences Unit, Glasgow G12 8RZ

Correspondence to: M Bloor M.Bloor{at}socsci.gla.ac.uk

Objectives To examine the "Scottish effect"—namely, the growing divergence between mortality in Scotland and England that is not explained by national differences in levels of deprivation—and, more specifically, to examine the extent to which the Scottish effect is explained by cross national differences in the prevalence of problem drug use.

Design Secondary analysis of cohort study (the DORIS study).

Participants 1033 Scottish drug users recruited to the cohort study in 33 drug treatment facilities across Scotland in 2001-2 and followed up 33 months later in 2004-5.

Results 38 deaths occurred in the cohort, giving a standardised mortality ratio for the cohort of 1244 (95% credible interval 876 to 1678). Only 22 of the 38 deaths in drug users were classified as drug related deaths. From estimates of the size of the problem drug using populations in both England and Scotland, the contribution of deaths in drug users to national death rates can be estimated: the attributable risk fraction for Scotland is 17.3% (12.3% to 22.8%) and that for England is 11.1% (7.8% to 14.8%). Excluding estimated numbers of deaths in drug users would bring down age standardised mortality at ages 15-54 years from 196 to 162 per 100 000 in Scotland and from 138 to 122 per 100 000 in England; 32.0% (22.3% to 43.0%) of the excess mortality in Scotland is due to drug use.

Conclusion Although problem drug use is a low prevalence risk behaviour, it carries a high mortality; the standardised mortality ratio for Scottish drug users is 12 times as high as for the general population. The higher prevalence of problem drug use in Scotland than in England accounts for a third of Scotland’s excess mortality over England. Successful public health efforts to reduce the prevalence of problem drug use in Scotland or deaths in Scottish drug users would have a dramatic impact on overall mortality in Scotland.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study
C McCowan, B Kidd, and T Fahey
BMJ 2009 338: b2225. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • McCowan, C, Kidd, B, Fahey, T (2009). Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ 338: b2225-b2225 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Death due to problem drug use: Tip of the iceberg?
Sahoo Saddichha
bmj.com, 24 Jul 2008 [Full text]
Stretching credulity
Harold Saxon
bmj.com, 24 Jul 2008 [Full text]
Not a third of all excess mortality
David S Gordon
bmj.com, 18 Aug 2008 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ